BMP 2 gene therapy

Drug Profile

BMP 2 gene therapy

Alternative Names: AAV-BMP2

Latest Information Update: 24 Aug 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Washington University School of Medicine
  • Class
  • Mechanism of Action Osteogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Bone resorption

Most Recent Events

  • 24 Aug 2006 No development reported - Preclinical for Bone resorption in USA (Parenteral)
  • 12 Sep 2003 A preclinical study has been added to the Musculoskeletal disorders pharmacodynamics section
  • 09 Feb 1999 Preclinical development for Bone resorption in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top